Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
Quick Stats
Jan 30, 202649.6
AI Score
HOLD0.02
Volume Ratio
Mar 19, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
PCSA Stock Summary
Last updated Jan 30, 2026
PCSA is currently trading at $3, positioned above its 200-day moving average of $0.73, indicating a long-term uptrend. The stock has a 52-week range of $0.1095 to $8.88.
Technical Analysis: The 50-day moving average stands at $2.17, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 50.735, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.055, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PCSA at 49.6/100 with a HOLD recommendation.
PCSA (Processa Pharmaceuticals, Inc. Common) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 50.735 |
| CMF (20) | -0.055 |
| ROC (10) | -19.137 |
| ADX (14) | 53.569 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.192 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -91.954 |
| MFI (14) | 47.879 |
PCSA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
PCSA Price vs Max Options Open Interest
PCSA Max Change In Options Open Interest
PCSA Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PCSA Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PCSA Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
PCSA Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Processa Pharmaceuticals, Inc. Common is above both 50 Day and 200 Day SMA which is considered Bullish.
PCSA Moving Averages Analysis
Processa Pharmaceuticals, Inc. Common has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Processa Pharmaceuticals, Inc. Common has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
PCSA (Processa Pharmaceuticals, Inc. Common) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.19 |
| 20 | 3.26 |
| 30 | 3.44 |
| 50 | 2.17 |
| 100 | 1.23 |
| 200 | 0.73 |
PCSA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 6.8 million |
| Earnings/Share ($) | -28.75 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -10.75 |
| EPS Estimate Next Year ($) | -3.75 |
| WallStreet Target Price ($) | 25 |
| Most Recent Quarter |
The news is about various stocks experiencing significant price movements and potential breakouts. Stocks like YYAI, BURU, PCSA, DVLT, and OPEN have seen massive volume and price increases. TGL is expected to run hard off of news once discovered. SNGX has a price target of $2.50 and PCSA has made a solid move, but is suspiciously holding at $0.50. PCSA has already seen a 40% increase and BURU has gone from $0.14 to $0.85. Traders are advised not to miss out on potential opportunities with stocks like ADAP, BURU, PCSA, BJDX, and XBIO.
Updated 2025-10-08 12:00:03